These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34860565)

  • 1. Accuracy of Pathologic Diagnosis in Patients With Lymphoma and Survival: A Prospective Analysis From Botswana.
    Chipidza FE; Kayembe MKA; Nkele I; Efstathiou JA; Chabner BA; Abramson J; Dryden-Peterson SL; Sohani AR
    JCO Glob Oncol; 2021 Sep; 7():1620-1632. PubMed ID: 34860565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology review identifies frequent misdiagnoses in recurrent classic Hodgkin lymphoma in a nationwide cohort: implications for clinical and epidemiological studies.
    Boot MV; Schaapveld M; Van den Broek EC; Hijmering NJ; Group P; Van der Oord K; Van Leeuwen FE; Dinmohamed AG; Koens L; De Jong D
    Haematologica; 2023 May; 108(5):1349-1358. PubMed ID: 36263842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of Secondary Non-Hodgkin Lymphomas Among Our Classical Hodgkin Lymphoma Patients: A Single-Centre Experience.
    Virga B; Pinczés L; Illés Á; Miltényi Z; Magyari F; Méhes G; Simon Z
    Cureus; 2024 Jun; 16(6):e63307. PubMed ID: 39070524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
    Gonzalez CL; Medeiros LJ; Jaffe ES
    Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of lymphoid lesions of the head and neck using combined fine needle aspiration cytology and flow cytometry: Accuracy and pitfalls.
    Crous H; Gillam A; Kalokerinos MA; Knezevic S; Hobson P; Papadimos DJ; Shield PW
    Cytopathology; 2019 Jul; 30(4):370-377. PubMed ID: 30985042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of primary mediastinal large B cell lymphoma by flow cytometry.
    Cherian S; Fromm JR
    Cytometry B Clin Cytom; 2018 May; 94(3):459-467. PubMed ID: 28732145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma.
    Kim HJ; Kim HK; Park G; Min SK; Cha HJ; Lee H; Choi SJ; Na HY; Choe JY; Kim JE
    Diagn Pathol; 2019 Dec; 14(1):133. PubMed ID: 31831043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients.
    Chen-Liang TH; Martin-Santos T; Jerez A; Senent L; Orero MT; Remigia MJ; Muiña B; Romera M; Fernandez-Muñoz H; Raya JM; Fernandez-Gonzalez M; Lancharro A; Villegas C; Carlos Herrera J; Frutos L; Luis Navarro J; Uña J; Igua C; Sanchez-Vaño R; Cozar Mdel P; Contreras J; Sanchez-Blanco JJ; Perez-Ceballos E; Ortuño FJ
    Am J Hematol; 2015 Aug; 90(8):686-90. PubMed ID: 25925613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors.
    Xavier AC; Armeson KE; Hill EG; Costa LJ
    Cancer; 2013 Sep; 119(18):3385-92. PubMed ID: 23797978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and misdiagnosed analysis of primary pulmonary lymphoma: a retrospective study.
    Yao D; Zhang L; Wu PL; Gu XL; Chen YF; Wang LX; Huang XY
    BMC Cancer; 2018 Mar; 18(1):281. PubMed ID: 29530011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ and CD8+ T-cell kinetics in aviremic HIV-infected patients developing Hodgkin or non-Hodgkin lymphoma.
    Hoffmann C; Schommers P; Wolf E; Müller M; Schultze A; Krznaric I; Stoehr A; Wolf T; Fäktenheuer G; Stier B; Wyen C; Hentrich M
    AIDS; 2016 Mar; 30(5):753-60. PubMed ID: 26605513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study.
    Pavlovsky M; Cubero D; Agreda-Vásquez GP; Enrico A; Mela-Osorio MJ; San Sebastián JA; Fogliatto L; Ovilla R; Avendano O; Machnicki G; Barreyro P; Trufelli D; Villanova P
    JCO Glob Oncol; 2022 Mar; 8():e2100265. PubMed ID: 35486884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics, pathological distribution, and prognostic factors in non-Hodgkin lymphoma of Waldeyer's ring: nationwide Korean study.
    Lee SJ; Suh CW; Lee SI; Kim WS; Lee WS; Kim HJ; Choi CW; Kim JS; Shin HJ;
    Korean J Intern Med; 2014 May; 29(3):352-60. PubMed ID: 24851070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas.
    Jaffe ES; Zarate-Osorno A; Kingma DW; Raffeld M; Medeiros LJ
    Ann Oncol; 1994; 5 Suppl 1():7-11. PubMed ID: 8172822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
    Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
    Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of lymphoma subtypes in Shanxi according to latest WHO classification].
    Wang JF; Wang YZ; Chen ZW; Taylor RC
    Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):218-23. PubMed ID: 16776979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Livin, a novel marker in lymphoma type distinction.
    Tanhaei AP; Ziaei A; Mazrouei S; Keyhanian K; Salehi M
    Ann Diagn Pathol; 2014 Jun; 18(3):157-62. PubMed ID: 24767895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous lymphocyte predominant Hodgkin's disease and large-cell lymphoma.
    Grossman DM; Hanson CA; Schnitzer B
    Am J Surg Pathol; 1991 Jul; 15(7):668-76. PubMed ID: 2058762
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.